3% Hypertonic saline vs normal saline nebulization in children with acute bronchiolitis. Critical appraisal of an article "Hypertonic (3%) saline vs 0.9% saline nebulization for acute viral bronchiolitis: A randomized controlled trial.

被引:2
|
作者
Yadav, Krishna K. [1 ]
机构
[1] King George Med Univ, Dept Pediat, Lucknow 226003, Uttar Pradesh, India
来源
关键词
Critical appraisal; 3% Saline nebulization; Bronchiolitis; Consort; 2010;
D O I
10.1016/j.cegh.2014.01.001
中图分类号
R1 [预防医学、卫生学];
学科分类号
1004 ; 120402 ;
摘要
Question: Nebulization with hypertonic saline have been shown to be effective in management of acute bronchiolitis in different studies. In the present study duration of hospital stay and clinical severity scores of children admitted with acute bronchiolitis were compared between two groups. One group received nebulization with 3% hypertonic saline while other group received nebulization with 0.9% normal saline. Methods: This study was a double blinded randomized controlled trial conducted in a tertiary care teaching hospital in Jaipur, India from September 2009 to December 2010. Study population included 250 hospitalized children aged 1-24 months with clinical diagnosis of acute bronchiolitis of moderate severity as assessed by clinical severity score proposed by Wang et al. The study population was randomized into two groups to receive either nebulization of 4 ml of 3% hypertonic saline or 4 ml of 0.9% saline, along with 2.5 mg salbutamol in both groups, at 4 hourly intervals till the patients were fit for discharge. Fitness for discharge was defined by authors as "feeding well, no need of IV fluids and oxygen therapy, clinical severity scores <= 3, absence of accessory muscle use or tachypnoea (respiratory rate < 31 breaths/min) and oxygen saturation > 92% on air". Main results: The results of the study were in three forms viz baseline characteristics, duration of hospital stay and improvement in clinical severity scores between above two groups. Baseline characteristics were similar in both groups. The clinical severity scores were recorded at the time of recruitment and twelve hourly thereafter till discharge. The median clinical severity scores of the two groups were similar at the time of recruitment and thereafter in two groups. The duration of hospital stay was 63.93 +/- 22.43 h in 3% saline group which was similar to 63.51 +/- 21.27 h in 0.9% saline group (P = 0.878). None of parents, caregivers or treating physicians were reported any adverse events in both groups. Conclusion: Nebulization with 0.9% normal saline or 3% hypertonic saline has got similar efficacy in terms of duration of hospital stay and improvement in clinical severity scores among the children admitted with acute bronchiolitis. Copyright (C) 2014, INDIACLEN. Publishing Services by Reed Elsevier India Pvt Ltd. All rights reserved.
引用
收藏
页码:141 / 142
页数:2
相关论文
共 50 条
  • [1] Hypertonic (3%) Saline Vs 0.9% Saline Nebulization for Acute Viral Bronchiolitis: A Randomized Controlled Trial
    Sharma, Bhagwan S.
    Gupta, Mukesh K.
    Rafik, Shaikh P.
    INDIAN PEDIATRICS, 2013, 50 (08) : 743 - 747
  • [2] Hypertonic (3%) saline Vs 0.9% saline nebulization for acute viral bronchiolitis: A randomized controlled trial
    Sharma B.S.
    Gupta M.K.
    Rafik S.P.
    Indian Pediatrics, 2013, 50 (8) : 743 - 747
  • [3] Normal Saline vs. Hypertonic Saline Nebulization for Acute Bronchiolitis: A Randomized Clinical Trial
    Reisi, Mohsen
    Afkande, Narges
    Golmakani, Hasan
    Khademian, Majid
    INTERNATIONAL JOURNAL OF PEDIATRICS-MASHHAD, 2018, 6 (11): : 8507 - 8516
  • [4] Comparison of 3% saline and 0.9% normal saline nebulization as diluent in children with bronchiolitis
    Sapkota, Shobha
    Kaleem, Ammara
    Huma, Suffura
    Din, Muhammad Aleem Ud
    Ahmad, Shabbir
    ShahAlam, Sobia
    JOURNAL OF THE PAKISTAN MEDICAL ASSOCIATION, 2021, 71 (03) : 822 - 825
  • [5] 3% Hypertonic Saline Versus Normal Saline in Inpatient Bronchiolitis: A Randomized Controlled Trial
    Silver, Alyssa H.
    Esteban-Cruciani, Nora
    Azzarone, Gabriella
    Douglas, Lindsey C.
    Lee, Diana S.
    Liewehr, Sheila
    Nazif, Joanne M.
    Agalliu, Ilir
    Villegas, Susan
    Rhim, Hai Jung H.
    Rinke, Michael L.
    O'Connor, Katherine
    PEDIATRICS, 2015, 136 (06) : 1036 - 1043
  • [6] 7% Hypertonic Saline in Acute Bronchiolitis: A Randomized Controlled Trial
    Jacobs, Jonathan D.
    Foster, Megan
    Wan, Jim
    Pershad, Jay
    PEDIATRICS, 2014, 133 (01) : E8 - E13
  • [7] 7% Hypertonic saline in acute bronchiolitis: A Randomized Controlled Trial
    Mathew, Jospeh L.
    Shivbalan, So.
    Sehgal, Vineet
    INDIAN PEDIATRICS, 2014, 51 (03) : 221 - 222
  • [8] Comparative Study of 3% Hypertonic Saline Nebulisation Versus 0.9% Normal Saline Nebulisation for Treating Acute Bronchiolitis
    Bashir, Tanveer
    Reddy, Kallem Venkat
    Ahmed, Kaiser
    Shafi, Saima
    JOURNAL OF CLINICAL AND DIAGNOSTIC RESEARCH, 2018, 12 (06) : SC05 - SC08
  • [9] Early Halt of a Randomized Controlled Study with 3% Hypertonic Saline in Acute Bronchiolitis
    Carsin, Ania
    Sauvaget, Emilie
    Bresson, Violaine
    Retornaz, Karine
    Cabrera, Maria
    Jouve, Elisabeth
    Truillet, Romain
    Bosdure, Emmanuelle
    Dubus, Jean-Christophe
    RESPIRATION, 2017, 94 (03) : 251 - 257
  • [10] Saline in Acute Bronchiolitis RCT and Economic evaluation: hypertonic saline in acute bronchiolitis - randomised controlled trial and systematic review
    Everard, Mark L.
    Hind, Daniel
    Ugonna, Kelechi
    Freeman, Jennifer
    Bradburn, Mike
    Dixon, Simon
    Maguire, Chin
    Cantrill, Hannah
    Alexander, John
    Lenney, Warren
    McNamara, Paul
    Elphick, Heather
    Chetcuti, Philip A. J.
    Moya, Eduardo F.
    Powell, Colin
    Garside, Jonathan P.
    Chadha, Lavleen Kumar
    Kurian, Matthew
    Lehal, Ravinderjit S.
    MacFarlane, Peter I.
    Cooper, Cindy L.
    Cross, Elizabeth
    HEALTH TECHNOLOGY ASSESSMENT, 2015, 19 (66) : 1 - +